Login
Toggle navi gation
MENU
MENU
About
BioUtah Mission-Vision
Our Team
Board of Directors
Elite Members
Partnerships
Job Posting
Member-to-member Deals
Membership
Why Join BioUtah?
Apply for Membership
Member Login
Purchasing Discount Program
Non-dilutive Funding
Membership Directory
Advocacy
News/Events
Reports & Publications
Events
Life Sciences News
Podcasts
Why Utah?
Life Sciences Report
Newsletter
BioHive
Advisory Board
Advocacy
Advocacy New
Annual Legislative Luncheon
BIO Business Solutions
BIO Business Solutions
BioHive
Biosphere Magazine Acknowledgment Submission
COVID-19 Resources
Business Resources
COVID-19 Events
COVID-19 Federal News
COVID-19 State News
HHS/FDA News
Utah’s Life Sciences Companies
Workplace Safety
Events
Generic Integration Page
Governance
Committees
Index
BioUtah Summary Overview
Slide 1
Slide 2
Investment
Jobs
Life Sciences Reports & Publications
Member Login
Membership Application
Membership Levels
Member Deals
Member Information
Membership Directory
Memberzone
Networking
Newsletter
Non-dilutive Government Funding Options
Partners (New)
Partnerships
RAPS Utah
Sitemap
Sponsors and Partners
Elite Members and Partnerships
The Value of Membership
How to Get Involved
Join BioUtah
About Membership
Standard Membership Levels
Why Join? Who Should Join?
Member Spotlight
Membership Directory
Utah Life Sciences News
National Life Sciences News
Why Utah?
Interviews with Utah Life Sciences Leaders
Resources
Utah Life Sciences Industry Reports
Workforce
“Invest in You Too”
Medical Innovations Pathways
BioUtah Mission-Vision
Board Members
Our Team
Sponsors
Who Are We
MENU
MENU
About
BioUtah Mission-Vision
Our Team
Board of Directors
Elite Members
Partnerships
Job Posting
Member-to-member Deals
Membership
Why Join BioUtah?
Apply for Membership
Member Login
Purchasing Discount Program
Non-dilutive Funding
Membership Directory
Advocacy
News/Events
Reports & Publications
Events
Life Sciences News
Podcasts
Why Utah?
Life Sciences Report
Newsletter
BioHive
Join Now
Utah Life Sciences News & Events
biout_email_stratushr_event
March 27, 2020
Recent News
bioMérieux receives De Novo FDA Authorization for its BIOFIRE® Joint Infection (JI) Panel
PolarityTE to Effectuate 1-for-25 Reverse Stock Split
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update
PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®